Cover Image

Current Approaches and Strategies Applied in First‐in‐class Drug Discovery

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Idrees Mohammed, Someswar Rao Sagurthi
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	ChemMedChem
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Accelerating Drug Discovery through Knowledge Sharing
by: Rory C. McAtee
Published: (2026)

Biosynthesis of Natural and Unnatural Perylenequinones for Drug Development
by: Zengping Su, et al.
Published: (2024)

Drug Discovery Summit: 14 th Swiss Course on Medicinal Chemistry
by: Céline Schuppisser, et al.
Published: (2024)

Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery
by: Ariane F. Hübner, et al.
Published: (2026)

Fluorescence‐Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines
by: Jan Voldřich, et al.
Published: (2024)

How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
by: Tim Kirkman, et al.
Published: (2024)

Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
by: Chao Tang, et al.
Published: (2026)

Structure–Property Associations: Breaking Paradigms for Linking Chemical Structures and Biological Properties in Drug Discovery
by: Edgar López‐López, et al.
Published: (2025)

Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
by: Jochem Nelen, et al.
Published: (2026)

Exploring Synthesis Strategies and Interactions between MOFs and Drugs for Controlled Drug Loading and Release, Characterizing Interactions through Advanced Techniques
by: Lidia E. Chiñas‐Rojas, et al.
Published: (2024)

Inducing Targeted Protein Degradation: From Chemical Biology to Drug Discovery and Clinical Applications. Edited by Philipp Cromm
by: Kirsten McAulay
Published: (2024)

Cover Feature: Direct Inhibition of the YAP : TEAD Interaction: An Unprecedented Drug Discovery Challenge (ChemMedChem 19/2024)
by: Patrick Chène
Published: (2024)

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
by: Ilaria Cursaro, et al.
Published: (2024)

Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains
by: Biswajit Naik, et al.
Published: (2025)

Current Small Molecule–Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics
by: Nitesh Sanghai, et al.
Published: (2024)

Is ASCT2 a Suitable Vector for the Selective Delivery of Anticancer Drugs? Modification of Glutamine at Either the Carboxylate or the Side Chain Hinders Binding and Transport
by: Vinitha M, et al.
Published: (2024)

Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
by: Jingjing Zhang, et al.
Published: (2024)

Nanomaterials‐Based Targeting of Long Non‐Coding RNAs in Cancer: A Cutting‐Edge Review of Current Trends
by: Fatemeh Davodabadi, et al.
Published: (2024)

Recent Progress on Topical Drug Therapy for Corneal Neovascularization
by: Xin‐Can Huang, et al.
Published: (2025)

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
by: Alisa Heuser, et al.
Published: (2024)

Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance
by: Linjia Su, et al.
Published: (2024)

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation
by: Jinmin Miao, et al.
Published: (2024)

Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
by: Yaxin Lei, et al.
Published: (2025)

Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
by: Sadık Hüseyin Cemali, et al.
Published: (2025)

From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
by: Mehmet Ali Yucel, et al.
Published: (2024)

Front Cover: r‐BRICS – A Revised BRICS Module That Breaks Ring Structures and Carbon Chains (ChemMedChem 4/2024)
by: Leili Zhang, et al.
Published: (2024)

Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
by: Isabelle Lyothier, et al.
Published: (2025)

Discovery of New CDDO‐Imidazole Derivatives as Potential Antitumor Agents
by: Yanqing Li, et al.
Published: (2026)

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape
by: Pengwen Chen, et al.
Published: (2024)

Hybrid Molecules as Efficient Drugs against Multidrug‐Resistant Malaria Parasites
by: Anne Robert, et al.
Published: (2025)

The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design
by: Konstantina Nikovia, et al.
Published: (2026)

In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
by: Frankie S. Mak, et al.
Published: (2026)

Nonsteroidal Anti‐Inflammatory Drugs as Modulators of Cation Channels: Fenamates Repurposing in Channelopathies
by: Paola Laghetti, et al.
Published: (2025)

Design, Synthesis, and Biological Evaluation of Evodiamine Derivatives as Antibody–Drug Conjugate Payloads
by: Ruifeng Liu, et al.
Published: (2025)

A New Paradigm for Drug Deuteration Based on Computed Binding Isotope Effects
by: Agata Paneth, et al.
Published: (2025)

Imidazole‐Based Liposomes: Emerging pH‐Sensitive Drug Delivery Tools
by: Faeze Shojaeinia, et al.
Published: (2025)

Corrin Ring Modification in Peptide Drug Development – a Brief History of “Corrination”
by: Nancy Cham, et al.
Published: (2025)

Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9
by: Philipp Grosche, et al.
Published: (2024)

Ligand Screening and Discovery Using Cocktail Soaking and Automated Microcrystal Electron Diffraction
by: Jieye Lin, et al.
Published: (2025)

Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light‐Induced PPARα Activation
by: Minh Sai, et al.
Published: (2024)